药物对比
Linagliptin vs Tolbutamide
比较 Linagliptin（Tradjenta）与 Tolbutamide 治疗2型糖尿病。作用机制、低血糖风险、副作用的差异，以及哪种可能更适合患者。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when evaluating a switch from older first-generation sulfonylureas like Tolbutamide to modern DPP-4 inhibitors like Linagliptin for type 2 diabetes safety.
结论
Linagliptin typically offers a superior safety profile over Tolbutamide with less hypoglycemia, but neither is universally better without medical input.
全部药物对比